Glipizide is a sulfonylurea indicated for type 2 diabetes mellitus. We supply it to US manufacturers of tablets and extended-release tablets.
Data from PubChem (CID 3478) and FDA’s substance registry
CAS number
29094-61-9
Molecular formula
C21H27N5O4S
Molecular weight
445.5g/mol
FDA UNII
IUPAC name
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
InChIKey
ZJJXGWJIGJFDTL-UHFFFAOYSA-N
- Appearance
- White or almost white, odorless crystalline powder.
- Solubility
- Insoluble in water and alcohols. Soluble in 0.1 N sodium hydroxide and freely soluble in dimethylformamide.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Insoluble in water, so dissolution is sensitive to particle size. State the range you developed with.
On the US market
- Reference product
- GlucotrolNDA 017783
- Approved ANDAs
- 12 with a marketed product
- Approved forms and strengths
- Tablet 2.5 mg, 5 mg, 10 mg, 15 mg
- Extended-release tablet 2.5 mg, 5 mg, 10 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com